Aker BioMarine ASA (OSL:AKBM)

Aker BioMarine ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	9,788	8,656	5,884	4,033	3,335	4,756
Market Cap Growth	61.74%	47.13%	45.89%	20.94%	-29.89%	-53.79%
Enterprise Value	11,454	10,398	7,308	8,170	7,246	7,421
Last Close Price	111.60	98.70	67.10	25.59	21.16	30.20
PE Ratio	-	-	2.87	-	33.85	-
Forward PE	42.38	39.34	179.33	80.58	30.13	-
PS Ratio	4.45	3.94	2.60	2.03	1.22	2.06
PB Ratio	6.75	5.97	2.98	1.09	0.89	1.46
P/TBV Ratio	35.96	31.80	7.96	1.85	1.54	2.68
P/FCF Ratio	-	-	-	265.14	-	-
P/OCF Ratio	220.67	195.16	42.45	8.39	22.42	207.63
EV/Sales Ratio	5.21	4.73	3.23	4.10	2.65	3.21
EV/EBITDA Ratio	21.28	19.32	16.45	84.81	12.04	21.88
EV/EBIT Ratio	89.47	81.22	-	-	45.12	-
EV/FCF Ratio	-668.37	-	-	537.11	-	-
Debt / Equity Ratio	1.27	1.27	0.85	1.07	1.01	0.88
Debt / EBITDA Ratio	3.41	3.41	3.58	27.68	5.82	7.37
Debt / FCF Ratio	-	-	-	262.00	-	-
Net Debt / Equity Ratio	1.15	1.15	0.76	1.00	0.95	0.85
Net Debt / EBITDA Ratio	3.10	3.10	3.39	38.47	5.87	8.15
Net Debt / FCF Ratio	-97.23	-97.23	-25.48	243.67	-14.13	-4.12
Asset Turnover	0.56	0.56	0.33	0.24	0.35	0.36
Inventory Turnover	1.18	1.18	0.93	0.65	0.97	1.38
Quick Ratio	0.83	0.83	1.21	0.83	0.84	0.93
Current Ratio	2.47	2.47	3.79	2.57	2.85	3.10
Return on Equity (ROE)	-1.76%	-1.76%	-5.29%	-8.67%	2.67%	-2.15%
Return on Assets (ROA)	2.06%	2.06%	-0.55%	-0.78%	1.29%	-0.59%
Return on Invested Capital (ROIC)	4.01%	4.13%	-1.02%	-1.40%	1.88%	-1.07%
Return on Capital Employed (ROCE)	4.10%	4.10%	-1.60%	-1.40%	2.30%	-1.00%
Earnings Yield	-2.35%	-2.66%	34.81%	-2.26%	2.95%	-1.48%
FCF Yield	-0.18%	-0.20%	-1.00%	0.38%	-7.50%	-14.10%
Buyback Yield / Dilution	-	-	-0.02%	-0.04%	-0.05%	-12.20%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.